Market Overview

Lakeland Industries Grabs Investor Interest With New Ebola Cases Reported

Lakeland Industries Grabs Investor Interest With New Ebola Cases Reported

Lakeland Industries, Inc. (NASDAQ: LAKE) closed Tuesday's trading session up 7.27 percent after the World Health Organization confirmed an Ebola outbreak in the Democratic Republic of the Congo.

The producer of protective clothing isn’t guaranteed a significant sales boost, according to Roth Capital Partners.

The Rating

Analyst Dave King maintained a Buy rating on Lakeland with an $18 price target.

The Thesis

The 2014 Ebola outbreak prompted 5-6-percent revenue growth for Lakeland over 12 months, with an estimated 20-40-cent pop in earnings per share, King said in a Tuesday note. 

“While Lakeland may be better-positioned this time around to capture any increased demand, certain governments may already have product on hand, and it remains unclear whether this current outbreak will reach 2014’s ‘international health emergency’ status,” the analyst said. 

The WHO has confirmed two cases of Ebola, with 21 suspected cases of viral hemorrhagic fever, King said. 

The analyst's bullish rating stands independent of any Ebola-related sales, he said. 

“We reiterate our Buy to reflect Lakeland’s expanding share in a growing end market, the potential for meaningful ROIC improvement through planned capacity addition and growth initiatives and LAKE’s attractive valuation and positioning as a takeout candidate." 

Price Action

Lakeland shares ended Tuesday's session at $15.50, up 7.27 percent. 

Related Links:

An Ebola-Fighting Portfolio For The Present And The Future

4 Ebola Researching Biotech Companies For Your Portfolio

Photo courtesy of Lakeland Industries.

Latest Ratings for LAKE

Dec 2020Roth CapitalMaintainsBuy
Jun 2020BenchmarkInitiates Coverage OnBuy
Aug 2017Roth CapitalInitiates Coverage OnBuy

View More Analyst Ratings for LAKE
View the Latest Analyst Ratings


Related Articles (LAKE)

View Comments and Join the Discussion!

Posted-In: Dave King Ebola ROTH Capital PartnersAnalyst Color Price Target Reiteration Analyst Ratings Best of Benzinga

Latest Ratings

DEBMO CapitalMaintains400.0
PRITruist SecuritiesMaintains165.0
SHAKJP MorganMaintains70.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at